CO6630193A2 - Inhibidores de la actividad de la proteína tirosina quinasa seleccionada - Google Patents

Inhibidores de la actividad de la proteína tirosina quinasa seleccionada

Info

Publication number
CO6630193A2
CO6630193A2 CO12207310A CO12207310A CO6630193A2 CO 6630193 A2 CO6630193 A2 CO 6630193A2 CO 12207310 A CO12207310 A CO 12207310A CO 12207310 A CO12207310 A CO 12207310A CO 6630193 A2 CO6630193 A2 CO 6630193A2
Authority
CO
Colombia
Prior art keywords
inhibitors
tyrosine kinase
protein activity
kinase protein
compounds
Prior art date
Application number
CO12207310A
Other languages
English (en)
Spanish (es)
Inventor
Stephane Raeppel
Lijie Zhan
Stephen Claridge
Franck Raeppel
Frederic Guadette
Arkadii Vaisburg
Original Assignee
Methylgene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Methylgene Inc filed Critical Methylgene Inc
Publication of CO6630193A2 publication Critical patent/CO6630193A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CO12207310A 2010-04-16 2012-11-15 Inhibidores de la actividad de la proteína tirosina quinasa seleccionada CO6630193A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32480310P 2010-04-16 2010-04-16

Publications (1)

Publication Number Publication Date
CO6630193A2 true CO6630193A2 (es) 2013-03-01

Family

ID=44788641

Family Applications (2)

Application Number Title Priority Date Filing Date
CO12207310A CO6630193A2 (es) 2010-04-16 2012-11-15 Inhibidores de la actividad de la proteína tirosina quinasa seleccionada
CO12207317A CO6640224A2 (es) 2010-04-16 2012-11-15 Inhibidores de la actividad de la proteína tirosina quinasa

Family Applications After (1)

Application Number Title Priority Date Filing Date
CO12207317A CO6640224A2 (es) 2010-04-16 2012-11-15 Inhibidores de la actividad de la proteína tirosina quinasa

Country Status (19)

Country Link
US (3) US8455484B2 (enExample)
EP (2) EP2563794A4 (enExample)
JP (2) JP2013523846A (enExample)
KR (2) KR20130100234A (enExample)
CN (2) CN103025740B (enExample)
AR (2) AR080871A1 (enExample)
AU (2) AU2011241420B2 (enExample)
CA (2) CA2796008A1 (enExample)
CO (2) CO6630193A2 (enExample)
EA (2) EA201291055A1 (enExample)
MX (2) MX2012012032A (enExample)
MY (1) MY157319A (enExample)
NZ (2) NZ602948A (enExample)
PH (2) PH12012502073A1 (enExample)
SG (2) SG184882A1 (enExample)
TW (2) TW201204735A (enExample)
UA (1) UA108878C2 (enExample)
WO (2) WO2011127567A1 (enExample)
ZA (2) ZA201207482B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2635131T3 (es) * 2007-08-29 2017-10-02 Methylgene Inc. Inhibidores de la actividad de la proteína tirosina cinasa
BRPI0923670A2 (pt) * 2008-03-05 2013-07-30 Methylgene Inc inibidores da atividade de proteÍna tirosina quinase e seu uso, bem como composiÇço compreendendo os mesmos
MY157319A (en) * 2010-04-16 2016-05-31 Methylgene Inc Inhibitors of protein tyrosine kinase activity
US20130090327A1 (en) * 2011-09-30 2013-04-11 Methylgene Inc. Inhibitors of Protein Tyrosine Kinase Activity
US20130096135A1 (en) * 2011-09-30 2013-04-18 Methylgene Inc. Selected Inhibitors of Protein Tyrosine Kinase Activity
WO2013044361A1 (en) * 2011-09-30 2013-04-04 Methylgene Inc. Inhibitors of protein tyrosine kinase activity
EP2791108B1 (en) 2011-12-15 2016-07-27 Pfizer Limited Sulfonamide derivatives
WO2016040554A1 (en) 2014-09-10 2016-03-17 Temple University-Of The Commonwealth System Of Higher Education Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
US20180221365A1 (en) * 2015-05-12 2018-08-09 Temple University-Of The Commonwealth System Of Higher Education Novel sigma-2 receptor binders and their method of use
JP6664170B2 (ja) * 2015-08-31 2020-03-13 広栄化学工業株式会社 アミノヒドロキシピリジン化合物の製造方法
CN108530464B (zh) * 2017-03-02 2020-10-27 深圳海王医药科技研究院有限公司 一种多靶点激酶抑制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050020619A1 (en) * 2003-07-24 2005-01-27 Patrick Betschmann Thienopyridine kinase inhibitors
WO2006010264A1 (en) * 2004-07-30 2006-02-02 Methylgene, Inc. Inhibitors of vegf receptor and hgf receptor signaling
AU2006229343A1 (en) * 2005-03-28 2006-10-05 Kirin Pharma Kabushiki Kaisha Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-Met autophosphorylation inhibiting potency
JO2787B1 (en) * 2005-04-27 2014-03-15 امجين إنك, Alternative amide derivatives and methods of use
EP1904504B1 (en) * 2005-05-20 2014-03-19 MethylGene Inc. Inhibitors of vegf receptor and hgf receptor signaling
BRPI0610322B8 (pt) * 2005-05-20 2021-05-25 Methylgene Inc inibidores de sinalização de receptor de vegf e de receptor de hgf e composição farmacêutica
ES2635131T3 (es) * 2007-08-29 2017-10-02 Methylgene Inc. Inhibidores de la actividad de la proteína tirosina cinasa
WO2009026720A1 (en) * 2007-08-29 2009-03-05 Methylgene Inc. Processes and intermediates for preparing fused heterocyclic kinase inhibitors
BRPI0923670A2 (pt) * 2008-03-05 2013-07-30 Methylgene Inc inibidores da atividade de proteÍna tirosina quinase e seu uso, bem como composiÇço compreendendo os mesmos
MY157319A (en) * 2010-04-16 2016-05-31 Methylgene Inc Inhibitors of protein tyrosine kinase activity
WO2013044361A1 (en) * 2011-09-30 2013-04-04 Methylgene Inc. Inhibitors of protein tyrosine kinase activity

Also Published As

Publication number Publication date
EA201291052A1 (ru) 2013-04-30
EA201291055A1 (ru) 2013-09-30
AR080875A1 (es) 2012-05-16
EP2563794A1 (en) 2013-03-06
PH12012502073A1 (en) 2013-02-11
ZA201207557B (en) 2013-06-26
JP2013525286A (ja) 2013-06-20
US8455484B2 (en) 2013-06-04
PH12012502070A1 (en) 2015-05-08
ZA201207482B (en) 2013-09-25
CN103025740B (zh) 2015-07-01
EP2563794A4 (en) 2013-12-04
NZ602954A (en) 2014-11-28
NZ602948A (en) 2014-09-26
AR080871A1 (es) 2012-05-16
UA108878C2 (ru) 2015-06-25
MX2012012032A (es) 2012-12-17
US20140315801A1 (en) 2014-10-23
TW201204735A (en) 2012-02-01
WO2011127565A1 (en) 2011-10-20
US8906852B2 (en) 2014-12-09
CO6640224A2 (es) 2013-03-22
US20110257100A1 (en) 2011-10-20
CN102947315A (zh) 2013-02-27
MY157319A (en) 2016-05-31
SG184883A1 (en) 2012-11-29
EP2563795A4 (en) 2013-10-23
AU2011241422A1 (en) 2012-11-01
TW201204734A (en) 2012-02-01
KR20130058006A (ko) 2013-06-03
AU2011241420B2 (en) 2015-04-16
CN103025740A (zh) 2013-04-03
MX2012012031A (es) 2012-12-17
WO2011127567A1 (en) 2011-10-20
SG184882A1 (en) 2012-11-29
JP2013523846A (ja) 2013-06-17
CA2796008A1 (en) 2011-10-20
KR20130100234A (ko) 2013-09-10
AU2011241422B2 (en) 2015-05-07
CA2796054A1 (en) 2011-10-20
EP2563795A1 (en) 2013-03-06
US20110257175A1 (en) 2011-10-20

Similar Documents

Publication Publication Date Title
CO6630193A2 (es) Inhibidores de la actividad de la proteína tirosina quinasa seleccionada
CR10868A (es) Derivados de dihidropiridina utiles como inhibidores de la proteina quinasa
BR112014004560A2 (pt) compostos e composições como inibidores de c-kit quinase
ECSP12011720A (es) Compuestos heterocíclicos y usos de los mismos
CO2018005640A2 (es) Compuestos inhibidores de jak quinasa para el tratamiento de enfermedad respiratoria
CO2017012267A2 (es) Compuestos de naftiridina como inhibidores de la quinasa jak
DOP2012000257A (es) Derivados del acido 1-amino-2-ciclopropiletilboronico
EA200900983A1 (ru) Соединения и композиции в качестве ингибиторов киназы
CR20150487A (es) Compuestos de biaril-amida como inhibidores de cinasa
CO6361936A2 (es) Imidazopiridazinacarbonitrilos utiles como inhibidores de quinasa
CO6761389A2 (es) Inhibidores de nampt y rock
NI201200029A (es) Compuestos y composiciones como inhibidores de cinasa de proteína
GT201300258A (es) Derivados de pirazoloespirocetona para uso como inhibidores de acetil-coa carboxilasa
EA201490042A1 (ru) Азетидинил-фенил-, пиридил- или пиразинилкарбоксамидные производные как ингибиторы jak
BR112014004319A2 (pt) compostos e composições como inibidores de c-kit cinase
EA201391230A1 (ru) Соединения и композиции в качестве ингибиторов trk
NI201100166A (es) Derivados de benzofuranilo utilizados como inhibidores de glucoquinasa
GT201400036A (es) Compuestos y composiciones como inhibidores de la quinasa c - kit
MX351028B (es) Determinadadas entidades, composiciones y metodos quimicos.
CU20140072A7 (es) Derivados de dihidro-oxazina y dihidro-pirido-oxazina
UY32848A (es) Compuestos heterocíclicos de oxima
EA201490272A1 (ru) Новые 4-пиперидинильные соединения для применения в качестве ингибиторов танкиразы
EA201500182A1 (ru) 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ
UY33655A (es) Co-cristales y sales de inhibidores de ccr30
CO6710916A2 (es) Inhibidores de notum pectinacetilesterasa y métodos de su uso

Legal Events

Date Code Title Description
FG Application granted